Cárdenas-Soto, Karla <br/><br/>
Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations.  [electronic resource] 

 -  Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   
 - 57-58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-2818 
<br/><br/><label>Standard No.: </label>10.1080/13506129.2019.1582520  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amyloid Neuropathies, Familial--drug therapy<br/>Benzoxazoles--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Prealbumin--genetics<br/>Quality of Life